Semigran Marc - Sep 3, 2021 Form 4 Insider Report for Renovacor, Inc. (RCOR)

Role
Chief Medical Officer
Signature
/s/ Joseph Carroll, as attorney-in-fact
Stock symbol
RCOR
Transactions as of
Sep 3, 2021
Transactions value $
$0
Form type
4
Date filed
9/8/2021, 06:59 PM
Previous filing
Sep 7, 2021
Next filing
Dec 22, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCOR Option Award $0 +170K $0.00 170K Sep 3, 2021 Common Stock 170K $7.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest and become exercisable in full on September 3, 2025, with 25% vesting on September 3, 2022, and the remainder vesting in equal monthly installments on the 3rd of each month for the remaining 36 months, subject to the continuous service of the Reporting Person on such vesting date.